{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:58:28Z","timestamp":1785355108123,"version":"3.55.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,7]]},"abstract":"<jats:p>\n                    Type 2 diabetes mellitus (T2DM) frequently coexists with hyperthyroidism (HT), compounding metabolic disturbances. However, the role of specific biomarkers in this comorbid condition remains unclear. This study investigates the clinical significance of serum semaphorin 5A (Sema5A) and insulin-like growth factor-binding protein 3 (IGFBP-3) in patients with T2DM and HT, focusing on their association with glucose metabolism and diagnostic potential. A total of 191 participants were enrolled and divided into 3 groups: T2DM with HT (n\u2005=\u200568), T2DM only (n\u2005=\u200551), and healthy controls (n\u2005=\u200572). Clinical parameters and serum levels of Sema5A, IGFBP-3, fasting plasma glucose, glycated hemoglobin, homeostasis model assessment of insulin resistance (HOMA-IR), and fasting insulin were measured. Pearson correlation, logistic regression, and receiver operating characteristic curve analyses were performed to evaluate associations and diagnostic performance. Serum levels of Sema5A and IGFBP-3 were significantly elevated in the T2DM with HT group compared to other groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.01). Both biomarkers showed positive correlations with fasting plasma glucose, glycated hemoglobin, HOMA-IR, and fasting insulin (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Multivariate logistic regression identified Sema5A, IGFBP-3, HOMA-IR, and thyroid autoantibodies (thyroid-stimulating hormone receptor antibody and thyroid peroxidase antibody) as independent risk factors. Receiver operating characteristic analysis demonstrated strong diagnostic value for Sema5A (area under the curve\u2005=\u20050.793) and IGFBP-3 (area under the curve\u2005=\u20050.831). Elevated Sema5A and IGFBP-3 levels are closely associated with impaired glucose metabolism in T2DM patients with HT and may serve as promising biomarkers for early diagnosis and clinical assessment of this comorbidity.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043966","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:01:00Z","timestamp":1762538460000},"page":"e43966","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Clinical significance of serum Sema5A and IGFBP-3 in type 2 diabetes mellitus with hyperthyroidism"],"prefix":"10.1097","volume":"104","author":[{"given":"Yan","family":"Deng","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Wuhan Fifth Hospital, Wuhan, Hubei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4737-1545","authenticated-orcid":false,"given":"Ting","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Wuhan Fifth Hospital, Wuhan, Hubei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260729","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1038\/emm.2016.7","article-title":"Recent progress in genetic and epigenetic research on type 2 diabetes.","volume":"48","author":"Kwak","year":"2016","journal-title":"Exp Mol Med"},{"key":"R2-20260729","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s10787-023-01255-4","article-title":"The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM).","volume":"31","author":"Al-Kuraishy","year":"2023","journal-title":"Inflammopharmacology"},{"key":"R3-20260729","doi-asserted-by":"crossref","first-page":"904312","DOI":"10.3389\/fendo.2022.904312","article-title":"Bioinformatics analysis identifies potential ferroptosis key gene in type 2 diabetic islet dysfunction.","volume":"13","author":"Ye","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R4-20260729","first-page":"1473","article-title":"Platelet glycoprotein-Ib (GPIb) may serve as a bridge between type 2 diabetes mellitus (T2DM) and atherosclerosis, making it a potential target for antiplatelet agents in T2DM patients.","volume":"13","author":"Amalia","year":"2023","journal-title":"Life (Basel)"},{"key":"R5-20260729","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13643-024-02527-y","article-title":"Prevalence of thyroid dysfunction and associated factors among adult type 2 diabetes mellitus patients, 2000\u20132022: a systematic review and meta-analysis.","volume":"13","author":"Hadgu","year":"2024","journal-title":"Syst Rev"},{"key":"R6-20260729","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"R7-20260729","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.cmet.2024.07.011","article-title":"Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma.","volume":"36","author":"Li","year":"2024","journal-title":"Cell Metab"},{"key":"R8-20260729","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.molcel.2023.06.010","article-title":"Glucose-induced CRL4COP1-p53 axis amplifies glycometabolism to drive tumorigenesis.","volume":"83","author":"Su","year":"2023","journal-title":"Mol Cell"},{"key":"R9-20260729","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.gendis.2023.03.019","article-title":"Mitochondria-related signaling pathways involved in breast cancer regulate ferroptosis.","volume":"11","author":"Dong","year":"2023","journal-title":"Genes Dis"},{"key":"R10-20260729","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants.","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"R11-20260729","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/s41467-024-46725-7","article-title":"Structure and function of Semaphorin-5A glycosaminoglycan interactions.","volume":"15","author":"Nagy","year":"2024","journal-title":"Nat Commun"},{"key":"R12-20260729","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s11658-022-00395-9","article-title":"Circulating small extracellular vesicle-encapsulated SEMA5A-IT1 attenuates myocardial ischemia-reperfusion injury after cardiac surgery with cardiopulmonary bypass.","volume":"27","author":"Wu","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"R13-20260729","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/liv.15773","article-title":"Exosome-derived miR-182-5p promoted cholangiocarcinoma progression and vasculogenesis by regulating ADK\/SEMA5a\/PI3K pathway.","volume":"44","author":"Wang","year":"2024","journal-title":"Liver Int"},{"key":"R14-20260729","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.3390\/cimb46040194","article-title":"Autism spectrum disorder- and\/or intellectual disability-associated semaphorin-5A exploits the mechanism by which dock5 signalosome molecules control cell shape.","volume":"46","author":"Okabe","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"R15-20260729","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jcmgh.2020.06.006","article-title":"IGFBP-3: So much more than an IGF1\/2 binding protein.","volume":"10","author":"Mar\u00ed","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R16-20260729","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.beem.2015.06.003","article-title":"Insulin-like growth factor binding-protein-3 (IGFBP-3).","volume":"29","author":"Ranke","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R17-20260729","doi-asserted-by":"crossref","first-page":"118758","DOI":"10.1016\/j.lfs.2020.118758","article-title":"IGFBP-3 stimulates human osteosarcoma cell migration by upregulating VCAM-1 expression.","volume":"265","author":"Chao","year":"2021","journal-title":"Life Sci"},{"key":"R18-20260729","doi-asserted-by":"crossref","first-page":"153810","DOI":"10.1016\/j.phymed.2021.153810","article-title":"Gegen Qinlian Decoction ameliorates type 2 diabetes osteoporosis via IGFBP3\/MAPK\/NFATc1 signaling pathway based on cytokine antibody array.","volume":"94","author":"Yang","year":"2022","journal-title":"Phytomedicine"},{"key":"R19-20260729","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/aje\/kwv188","article-title":"Insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in relation to the risk of type 2 diabetes mellitus: results from the EPIC-Potsdam Study.","volume":"183","author":"Drogan","year":"2016","journal-title":"Am J Epidemiol"},{"key":"R20-20260729","doi-asserted-by":"crossref","first-page":"958218","DOI":"10.3389\/fendo.2022.958218","article-title":"Gut microbiota: a new target for T2DM prevention and treatment.","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R21-20260729","doi-asserted-by":"crossref","first-page":"13499","DOI":"10.1038\/s41598-023-40752-y","article-title":"Association between thyroid function and diabetes peripheral neuropathy in euthyroid type 2 diabetes mellitus patients.","volume":"13","author":"He","year":"2023","journal-title":"Sci Rep"},{"key":"R22-20260729","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1093\/rheumatology\/keab133","article-title":"TSP1 is the essential domain of SEMA5A involved in pannus formation in rheumatoid arthritis.","volume":"60","author":"Xiao","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R23-20260729","doi-asserted-by":"crossref","first-page":"3274467","DOI":"10.1155\/2023\/3274467","article-title":"SEMA5A-PLXNB3 axis promotes PDAC liver metastasis outgrowth through enhancing the Warburg Effect.","volume":"2023","author":"Wang","year":"2023","journal-title":"J Immunol Res"},{"key":"R24-20260729","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/cells9051261","article-title":"IGFBP-3\/IGFBP-3 receptor system as an anti-tumor and anti-metastatic signaling in cancer.","volume":"9","author":"Cai","year":"2020","journal-title":"Cells"},{"key":"R25-20260729","doi-asserted-by":"crossref","first-page":"e22062","DOI":"10.1096\/fj.202100710RR","article-title":"IGFBP-3 functions as a molecular switch that mediates mitochondrial and metabolic homeostasis.","volume":"36","author":"Stuard","year":"2022","journal-title":"FASEB J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043966","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:01:24Z","timestamp":1785351684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":25,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043966","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"2025-05-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}